Switching from Reference to Biosimilar Insulin Lispro for Patients with Diabetes Mellitus Type 1 or 2


( Last Updated : February 24, 2021)
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1554-000

Details


Question


  1. What is the clinical effectiveness of switching from reference to biosimilar insulin lispro in adult or pediatric patients with diabetes mellitus (type 1 or 2)?


Key Message

One randomized controlled trial was identified regarding the clinical effectiveness of switching from reference to biosimilar insulin lispro in adult or pediatric patients with diabetes mellitus (type 1 or 2).